Group One Trading’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161K Buy
+2,200
New +$151K ﹤0.01% 4464
2025
Q1
Sell
-3,000
Closed -$190K 7951
2024
Q4
$190K Buy
3,000
+1,500
+100% +$86.8K ﹤0.01% 3972
2024
Q3
$73.7K Hold
1,500
﹤0.01% 4397
2024
Q2
$67.6K Sell
1,500
-5,700
-79% -$194K ﹤0.01% 4282
2024
Q1
$448K Buy
7,200
+5,900
+454% +$383K ﹤0.01% 2844
2023
Q4
$75.1K Buy
+1,300
New +$66.6K ﹤0.01% 4715
2023
Q3
Sell
-100
Closed -$4.44K 7950
2023
Q2
$4.44K Buy
+100
New +$3.55K ﹤0.01% 6771
2023
Q1
Sell
-83,700
Closed -$1.66M 7548
2022
Q4
$1.66M Buy
83,700
+80,473
+2,494% +$4.01M ﹤0.01% 1981
2022
Q3
$159K Buy
3,227
+1,517
+89% +$71.6K ﹤0.01% 4362
2022
Q2
$87K Buy
+1,710
New +$75.6K ﹤0.01% 5112
2022
Q1
Sell
-20
Closed -$2K 8331
2021
Q4
$2K Sell
20
-90
-82% -$8.82K ﹤0.01% 7884
2021
Q3
$13K Sell
110
-307
-74% -$42K ﹤0.01% 7386
2021
Q2
$81K Buy
417
+270
+184% +$88.8K ﹤0.01% 6164
2021
Q1
$60K Buy
+147
New +$65.6K ﹤0.01% 6090

Other funds holding IRON

Group One Trading's IRON Position: Q2 2026 in Review

Group One Trading sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 11 shares — an estimated $756 sold.

Group One Trading first reported a position in IRON in Q1 2021 and held it in 9 quarters. The position peaked at $271K in Q1 2021. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Group One Trading reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 11 Disc Medicine shares in Q2 2026, an estimated $756.
  • Group One Trading first reported a position in Disc Medicine in Q1 2021 and held it in 9 quarters.
  • Group One Trading's Disc Medicine position peaked at $271K in Q1 2021.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.